Cargando…

Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities

OBJECTIVE: This study examined the relationship between specific metabolic and vascular risk factors and cognition in adults with severe obesity. METHODS: 129 adults (with BMI ≥ 35 kg/m(2)) underwent a baseline clinical evaluation and neuropsychological assessment. Regression analyses examined the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Heshan J., Cohen, Ronald, Gullett, Joseph M., Friedman, Jeffrey, Ayzengart, Alexander, Porges, Eric, Woods, Adam J., Gunstad, John, Ochoa, Christa M., Cusi, Kenneth, Gonzalez-Louis, Rachel, Donahoo, William T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666310/
https://www.ncbi.nlm.nih.gov/pubmed/31116012
http://dx.doi.org/10.1002/oby.22508
_version_ 1783439974781157376
author Fernando, Heshan J.
Cohen, Ronald
Gullett, Joseph M.
Friedman, Jeffrey
Ayzengart, Alexander
Porges, Eric
Woods, Adam J.
Gunstad, John
Ochoa, Christa M.
Cusi, Kenneth
Gonzalez-Louis, Rachel
Donahoo, William T.
author_facet Fernando, Heshan J.
Cohen, Ronald
Gullett, Joseph M.
Friedman, Jeffrey
Ayzengart, Alexander
Porges, Eric
Woods, Adam J.
Gunstad, John
Ochoa, Christa M.
Cusi, Kenneth
Gonzalez-Louis, Rachel
Donahoo, William T.
author_sort Fernando, Heshan J.
collection PubMed
description OBJECTIVE: This study examined the relationship between specific metabolic and vascular risk factors and cognition in adults with severe obesity. METHODS: 129 adults (with BMI ≥ 35 kg/m(2)) underwent a baseline clinical evaluation and neuropsychological assessment. Regression analyses examined the relationship between cognition and medical factors (BMI, hemoglobin HbA1c, diabetes, hypertension, CPAP use, obstructive sleep apnea [OSA], and osteoarthritis). RESULTS: Diabetes was associated with deficits in overall cognitive performance, and in the executive, processing speed and verbal fluency domains. HbA1c was inversely related to overall cognitive performance and deficits in the attention domain. Participants using CPAP to treat OSA had stronger learning and memory performance, whereas OSA was associated with reduced total learning. Elevated BMI together with diabetes diagnosis were associated with reduced verbal fluency and greater variability in sustained attention. CONCLUSIONS: Obesity-associated comorbidities, most notably appear to have a greater relative influence on cognitive performance than BMI itself in adults with severe obesity. This likely reflects the fact the very elevated BMI was ubiquitous, and thereby probably exerted a similar influence among all adults in the cohort. Accordingly, in the context of severe obesity, diabetes and other comorbidities may have greater sensitivity to cognitive deficits than BMI alone. CLINICALTRIALS.GOV REGISTRY: Name: Obesity and Type 2 Diabetes, Bariatric Surgery Effects on Brain Function URL: https://clinicaltrials.gov/ct2/show/NCT02137070 NCT Identifier: Other Study ID Numbers: 201400034-N 1R01DK099334–01A1 (U.S. NIH Grant/Contract)
format Online
Article
Text
id pubmed-6666310
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-66663102019-11-22 Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities Fernando, Heshan J. Cohen, Ronald Gullett, Joseph M. Friedman, Jeffrey Ayzengart, Alexander Porges, Eric Woods, Adam J. Gunstad, John Ochoa, Christa M. Cusi, Kenneth Gonzalez-Louis, Rachel Donahoo, William T. Obesity (Silver Spring) Article OBJECTIVE: This study examined the relationship between specific metabolic and vascular risk factors and cognition in adults with severe obesity. METHODS: 129 adults (with BMI ≥ 35 kg/m(2)) underwent a baseline clinical evaluation and neuropsychological assessment. Regression analyses examined the relationship between cognition and medical factors (BMI, hemoglobin HbA1c, diabetes, hypertension, CPAP use, obstructive sleep apnea [OSA], and osteoarthritis). RESULTS: Diabetes was associated with deficits in overall cognitive performance, and in the executive, processing speed and verbal fluency domains. HbA1c was inversely related to overall cognitive performance and deficits in the attention domain. Participants using CPAP to treat OSA had stronger learning and memory performance, whereas OSA was associated with reduced total learning. Elevated BMI together with diabetes diagnosis were associated with reduced verbal fluency and greater variability in sustained attention. CONCLUSIONS: Obesity-associated comorbidities, most notably appear to have a greater relative influence on cognitive performance than BMI itself in adults with severe obesity. This likely reflects the fact the very elevated BMI was ubiquitous, and thereby probably exerted a similar influence among all adults in the cohort. Accordingly, in the context of severe obesity, diabetes and other comorbidities may have greater sensitivity to cognitive deficits than BMI alone. CLINICALTRIALS.GOV REGISTRY: Name: Obesity and Type 2 Diabetes, Bariatric Surgery Effects on Brain Function URL: https://clinicaltrials.gov/ct2/show/NCT02137070 NCT Identifier: Other Study ID Numbers: 201400034-N 1R01DK099334–01A1 (U.S. NIH Grant/Contract) 2019-05-22 2019-07 /pmc/articles/PMC6666310/ /pubmed/31116012 http://dx.doi.org/10.1002/oby.22508 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Fernando, Heshan J.
Cohen, Ronald
Gullett, Joseph M.
Friedman, Jeffrey
Ayzengart, Alexander
Porges, Eric
Woods, Adam J.
Gunstad, John
Ochoa, Christa M.
Cusi, Kenneth
Gonzalez-Louis, Rachel
Donahoo, William T.
Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title_full Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title_fullStr Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title_full_unstemmed Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title_short Neurocognitive deficits in a Class II and Class-III obesity cohort: contributions of type-2 diabetes and other comorbidities
title_sort neurocognitive deficits in a class ii and class-iii obesity cohort: contributions of type-2 diabetes and other comorbidities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666310/
https://www.ncbi.nlm.nih.gov/pubmed/31116012
http://dx.doi.org/10.1002/oby.22508
work_keys_str_mv AT fernandoheshanj neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT cohenronald neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT gullettjosephm neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT friedmanjeffrey neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT ayzengartalexander neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT porgeseric neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT woodsadamj neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT gunstadjohn neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT ochoachristam neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT cusikenneth neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT gonzalezlouisrachel neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities
AT donahoowilliamt neurocognitivedeficitsinaclassiiandclassiiiobesitycohortcontributionsoftype2diabetesandothercomorbidities